CytoMed Therapeutics Limited (NASDAQ:GDTC – Get Free Report) saw a significant drop in short interest in the month of October. As of October 15th, there was short interest totalling 4,800 shares, a drop of 20.0% from the September 30th total of 6,000 shares. Approximately 0.1% of the shares of the company are sold short. Based […]